Dr Gary Moore Consulting Limited 11159124 false 2023-02-01 2024-01-31 2024-01-31 The principal activity of the company is that of research and experimental development on biotechnology. Digita Accounts Production Advanced 6.30.9574.0 true 11159124 2023-02-01 2024-01-31 11159124 2024-01-31 11159124 core:CurrentFinancialInstruments core:WithinOneYear 2024-01-31 11159124 bus:Micro-entities 2023-02-01 2024-01-31 11159124 bus:AuditExemptWithAccountantsReport 2023-02-01 2024-01-31 11159124 bus:FilletedAccounts 2023-02-01 2024-01-31 11159124 bus:SmallCompaniesRegimeForAccounts 2023-02-01 2024-01-31 11159124 bus:RegisteredOffice 2023-02-01 2024-01-31 11159124 bus:Director1 2023-02-01 2024-01-31 11159124 bus:Director2 2023-02-01 2024-01-31 11159124 bus:PrivateLimitedCompanyLtd 2023-02-01 2024-01-31 11159124 countries:UnitedKingdom 2023-02-01 2024-01-31 11159124 2022-02-01 2023-01-31 11159124 2023-01-31 11159124 core:CurrentFinancialInstruments core:WithinOneYear 2023-01-31 iso4217:GBP xbrli:pure

Registration number: 11159124

Dr Gary Moore Consulting Limited

Unaudited Filleted Financial Statements

for the Year Ended 31 January 2024

 

Dr Gary Moore Consulting Limited

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

2

 

Dr Gary Moore Consulting Limited

Company Information

Directors

Dr G W Moore

F A Oliva

Registered office

C/o Kishens Limited
13 Montpelier Avenue
Bexley
Kent
DA5 3AP

Accountants

Kishens Limited
Chartered Accountants
13 Montpelier Avenue
Bexley
Kent
DA5 3AP

 

Dr Gary Moore Consulting Limited

(Registration number: 11159124)
Balance Sheet as at 31 January 2024

2024
£

2023
£

Fixed Assets

1,911

1,770

Current assets

83,608

94,539

Creditors: Amounts falling due within one year

(831)

(9,837)

Net current assets

82,777

84,702

Total assets less current liabilities

84,688

86,472

Provisions for liabilities

(274)

(336)

Accruals and deferred income

(80,058)

(81,650)

 

4,356

4,486

Capital and reserves

4,356

4,486

1

General information

The company is a private company limited by share capital, incorporated in United Kingdom.

The address of its registered office is:
C/o Kishens Limited
13 Montpelier Avenue
Bexley
Kent
DA5 3AP
England

These financial statements were authorised for issue by the Board on 15 June 2024.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2023 - 2).

For the financial year ending 31 January 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

 

Dr Gary Moore Consulting Limited

(Registration number: 11159124)
Balance Sheet as at 31 January 2024

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 15 June 2024 and signed on its behalf by:
 

.........................................
Dr G W Moore
Director